Substituted indazole derivatives active as kinase inhibitors

Details for Australian Patent Application No. 2008280283 (hide)

Owner NERVIANO MEDICAL SCIENCES S.R.L.

Inventors Perrone, Ettore; Vanotti, Ermes; Orsini, Paolo; Lombardi Borgia, Andrea; Panzeri, Achille; Marchionni, Chiara; Menichincheri, Maria; Nesi, Marcella

Agent Griffith Hack

Pub. Number AU-A-2008280283

PCT Pub. Number WO2009/013126

Priority 07112881.3 20.07.07 EP

Filing date 8 July 2008

Wipo publication date 29 January 2009

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 March 2010 PCT application entered the National Phase

  PCT publication WO2009/013126 Priority application(s): WO2009/013126

18 March 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Feb 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008280284-Method and system for generating and controlling the distribution and use of personal promotion codes by targeted customers

2008280277-Soluble liquid formulations of quinclorac ammonium salts